Back to ABT Stock Lookup

ABT Related Analyst Ratings

May 28, 2013 08:34 AM Jefferies Boosts Price Targets Accross Pharmaceuticals Sector (ABT) (JNJ) (BMY) (more...)

May 28, 2013 07:31 AM Jefferies Upgrades Merck (MRK) to Buy; Top Restructuring Play

May 21, 2013 09:03 AM Gabelli Starts Abbott Labs (ABT) at Buy

May 20, 2013 08:30 AM Goldman Sachs Upgrades Abbott Labs (ABT) to Buy

Apr 19, 2013 08:28 AM Jefferies Lifts Est./PT on Abbott Labs (ABT) after In-Line Q1

Apr 12, 2013 06:38 AM Credit Suisse Starts Abbott Labs (ABT) at Neutral

Apr 10, 2013 08:30 AM Jefferies Lifts PT on Pharmaceuticals Stocks (ABBV) (NVS) (SNY) (PFE)

Feb 15, 2013 08:49 AM Stifel Nicolaus Starts Abbott Labs (ABT) at Buy

Jan 11, 2013 06:48 AM Barclays Starts Abbott Labs (ABT) at Equalweight

Jan 4, 2013 07:09 AM Deutsche Bank Downgrades Abbott Labs (ABT) to Hold to Reflect 'new ABT'

Jan 2, 2013 07:35 AM BMO Capital Starts Abbott Labs (ABT) at Outperform

Dec 20, 2012 02:12 PM Merck's (MRK) Tredaptive Miss May Benefit Amarin (AMRN) - Analyst

Dec 20, 2012 07:25 AM William Blair Starts Abbott Labs (ABT) at Outperform

Dec 13, 2012 03:34 PM Goldman Says Expect More Downside in Vertex Pharmaceuticals (VRTX)

Nov 12, 2012 12:00 PM Achillion Pharmaceuticals (ACHN) Weakness is a Buying Chance - Analyst

Nov 12, 2012 08:39 AM Deutsche Bank Maintains Buy on Gilead Sciences (GILD) after Strong Hepatitis C Combo Data

Nov 9, 2012 12:14 PM Abbott Labs (ABT) is Ripe for the Picking Before End of FY12 - Cramer

Oct 19, 2012 07:27 AM Wells Fargo Upgrades Abbott Labs (ABT) to Outperform

Oct 18, 2012 03:48 PM Jefferies Lifts Price Target on Abbott Labs (ABT)

Oct 18, 2012 07:51 AM Raymond James Downgrades Abbott Labs (ABT) to Market Perform

Sep 19, 2012 08:26 AM Jefferies Lifts Target on Abbott Labs (ABT) After Carving Out AbbVie

Sep 18, 2012 07:34 AM Leerink Swann Downgrades Abbott Labs (ABT) to Market Perform, Fully Valued Ahead of Split

Sep 14, 2012 01:54 PM UBS Lifts Target on Abbott Labs (ABT) Ahead of Split

Sep 12, 2012 07:52 AM Jefferies on Pharmaceutical: Top Picks Still ABT and NVS

Jul 23, 2012 07:24 AM Ascendiant Capital Starts Apricus Biosciences (APRI) at Strong Buy; Major Inflection Point

Jul 19, 2012 01:19 PM UBS Maintains a 'Buy' on Abbott Labs (ABT); Raising Price Target After Solid Quarter

Jul 13, 2012 08:32 AM Jefferies on Pharmaceuticals: Global Pharmaceuticals Q2'12 Earnings Preview; Where is it Safe to Hide?

Jun 29, 2012 03:51 PM Barclays on Pharmaceutical Stocks: Impact as SCOTUS Upholds Entire Affordable Care Act

Jun 5, 2012 02:47 PM Barclays Maintains an 'Equalweight' on Abbott Labs (ABT); Business Review & Form 10 Filing

Jun 5, 2012 08:25 AM Jefferies Said Abbott Labs (ABT) $76 Sum-of-the-Parts Valuation Supported

Apr 19, 2012 03:17 PM Brean Murray Carret & Co. Out In Defense of Achillion Pharmaceuticals (ACHN); Superficial Read-Through

Apr 19, 2012 08:42 AM Cantor Fitzgerald Cuts Price Target on Illumina (ILMN); Roche Walks

Apr 12, 2012 11:00 AM UPDATE - UBS Initiates Coverage on Ardea Biosciences (RDEA) with a Buy; Lesinurad Knocks Out Gout

Apr 4, 2012 12:57 PM Idenix (IDIX) Shares at Intraday Low; INFORM-SVR Data Has Negative Implications & Abbott (ABT) Positive Hep C Studies

Mar 19, 2012 10:26 AM UBS Reiterates a 'Buy' on Abbott Labs (ABT); Raising Price Target on Sum-of-Parts Review

Mar 19, 2012 07:24 AM Deutsche Bank Upgrades Abbott Labs (ABT) to Buy; Moving Ahead of 'Split'

Mar 8, 2012 08:22 AM Jefferies Boosts Price Target on Abbott Labs (ABT), Says Worth Much More in a Break-Up

Mar 1, 2012 11:54 AM UBS Maintains a 'Buy' on Abbott Labs (ABT); Better Late Than Never; Filling A Strategic Need

Jan 30, 2012 01:17 PM Q4 Preview: Pfizer (PFE) May Suffer Same Ailment as Peers: Strong Dollar Syndrome

Jan 18, 2012 01:18 PM Big Pharma Companies Drooling Over Idenix (IDIX) Following BMY/INHX Deal

Jan 9, 2012 09:33 AM Jefferies Raises Price Targets on Global Pharma Industry, Sets Top Picks of the Year

Jan 3, 2012 10:13 AM Abbott (ABT) Shares Fall as Morgan Stanley Downgrades to Equalweight

Dec 29, 2011 11:22 AM Caris & Co Start Coverage on Emergent BioSolutions (EBS); Shares Recover Despite Termination Notice From Abbott (ABT)

Dec 15, 2011 08:08 AM Leerink Swann Downgrades BioSante Pharmaceuticals (BPAX) to Market Perform; Pivotal BLOOM Trials Surprisingly Disappoint

Dec 9, 2011 01:20 PM Barclays Downgrades Abbott Labs (ABT) to Equalweight

Dec 9, 2011 01:15 PM Barclays Initiating Coverage: A Seamless Approach to Biopharmaceuticals

Nov 15, 2011 02:32 PM Barclays on U.S. Health Care Distribution & Technology: Branded Drug Price Survey - October

Oct 24, 2011 02:05 PM Barclays Maintains an 'Overweight' on Abbott Labs (ABT); New Pharma Business Outlook - Thriving Biotech or Pharma with Expiry Risk?

Oct 24, 2011 10:39 AM UBS Reiterates a 'Buy' on Abbott Labs (ABT); Valuing the Break-up

Oct 24, 2011 10:21 AM Brean Murray Carret & Co. Maintains a 'Buy' Pharmasset (VRUS); Abbott (ABT) Hep C Pipeline Not More Risky Than Any Other Four Drug Combo

Back to ABT Stock Lookup